SkinVision & VR/AR startup Virti join innovation accelerator

AMSTERDAM: Dutch startup joins NHS Innovation Accelerator. Amsterdam-headquartered SkinVision has announced that it has been selected to take part in the NHS Innovation Accelerator (NIA) programme – run by NHS England and the 15 Academic Health Science Networks – to accelerate the spread and uptake of its innovation across the health service.

SkinVision is the only non-UK startup to join this year’s cohort, and its offering is an app that allows people to monitor themselves for early signs of skin cancer by taking a photo of their skin spots with their smartphone.

“That photo is then run through a whole pipeline of machine learning networks that recognize the image and rate it as high, low, or medium risk; a traffic light system. This is all done within 20 seconds and this message is provided back to the customer.

“If it’s high risk, within 48 hours our dermatologists can get back to the customer,” SkinVision CEO Erik de Heus said last year, after the startup raised $7.6m in funding from Leo Pharma and PHS Fund, along with additional contributions from new backers whose names were not disclosed.

“We know from studies conducted here in the Netherlands that 70% of visits to GP related to suspicious skin spots are unnecessary, by the use of the app it is hoped that this number can be drastically reduced, freeing up GPs to run their practice more efficiently and to see more patients,” de Heus added this week in a statement.

Virti becomes first VR/AR startup to take part in the NIA scheme. Along with SkinVision, Virti has also been unveiled as one of the 13 fellows and the first VR/AR startup to join the NIA programme. Founded in late 2017, Virti uses VR and AR, combined with AI, to help healthcare professionals prepare for various aspects of clinical practice and evaluate them under pressure in different “hard-to-access” settings, with the aim to “reduce anxiety and improve human performance”.

“We are delighted to be the first Virtual and Augmented Reality company selected onto the NIA and proud that our evidence-based VR/AR training platform will now be scaled to further hospitals, physicians and patients through the NIA,” said Dr Alexander Young, CEO and founder of Virti.

“We are particularly excited to help deliver the NHS’ recently published ‘Health and Care Workforce Strategy to 2027’ and further demonstrate the positive impacts that immersive technology can have on corporates, employees and for healthcare.”

The other 11 innovations selected for the NIA are: ChatHealth, Mush, S12 Solutions, Population Genetic Testing, PrecisionPoint Transperineal Access System, Skin Analytics, Digital Continuing Healthcare (CHC) Assessment Process, Droplet, Echo, Low Carb Program and MIRA Rehab.